Efficacy, acceptability and tolerability of the new oral phosphate binder Lenziaren® in healthy cats fed a standard diet

BACKGROUND: The efficacy, acceptability and tolerability of the new oral phosphate binder Lenziaren® (SBR759) were evaluated in a randomized parallel-group design study in 36 healthy cats (n = 6 per group). Five groups were fed once daily with a commercial diet containing 0.2% phosphorus (“standard...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Jonathan N, Erasmus, Heidi L, Delport, Peet C, Bester, Ina CJ, Seewald, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226906/
https://www.ncbi.nlm.nih.gov/pubmed/25348573
http://dx.doi.org/10.1186/s12917-014-0258-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226906/
https://www.ncbi.nlm.nih.gov/pubmed/25348573
http://dx.doi.org/10.1186/s12917-014-0258-8

Ejemplares similares